Blogs

Pre-filled syringes have become a preferred packaging format for injectable pharmaceuticals, biologics, vaccines, and combination products. Their ready-to-administer configuration reduces preparation steps and supports convenient drug delivery in clinical and home-care settings. As pharmaceutical formulations become more sophisticated, package integrity evaluation receives greater attention throughout product development, validation, manufacturing, and shelf-life studies.

Container Closure Integrity Testing (CCIT) provides a scientific approach for evaluating the ability of syringe packaging systems to resist contamination ingress, moisture penetration, and product leakage. Unlike traditional packaging formats, pre-filled syringes contain multiple interfaces and movable components that create unique inspection considerations. These characteristics often influence the selection of CCIT technologies and testing strategies.

Growing Demand for Pre-Filled Syringe Systems

The pharmaceutical industry has seen significant growth in the use of pre-filled syringe systems. Increased adoption of biologics, injectable therapies, and self-administered treatments has contributed to this trend.

Several factors have influenced market expansion:

• Increased use of specialty pharmaceuticals
• Growth of biologic and biosimilar products
• Rising demand for patient-friendly drug delivery systems
• Expansion of combination products and autoinjectors
• Greater focus on dosing accuracy and convenience

Many injectable products contain sensitive formulations that require packaging capable of limiting exposure to environmental conditions throughout storage and distribution. As product values increase and packaging configurations become more specialized, manufacturers often seek highly sensitive methods for package integrity evaluation.

The combination of product complexity and advanced delivery systems has encouraged broader adoption of deterministic CCIT technologies capable of generating measurable and repeatable inspection data.

Unique Leak Risks in Syringe Packaging

Pre-filled syringes contain several sealing interfaces that may become potential leakage pathways. Unlike conventional rigid containers with a single closure interface, syringe systems incorporate multiple components assembled into a complete package.

Potential leak locations include:

• Needle shield interfaces
• Plunger stopper regions
• Glass-to-elastomer contact areas
• Tip cap sealing surfaces
• Cracks or fractures within the barrel

Leak pathways may develop during manufacturing, assembly, transportation, or long-term storage. Environmental conditions such as temperature fluctuations and mechanical stress can also influence package performance over time.

In addition, syringe packages frequently contain limited headspace volume. Smaller internal volumes can create challenges for some inspection methods and may require technologies capable of detecting extremely subtle changes associated with leakage.

Since leak paths vary in location, geometry, and size, package evaluation often involves technologies with high sensitivity and repeatability.

Challenges Related to Plunger Movement and Needle Shields

Pre-filled syringe systems contain movable and elastomeric components that introduce unique inspection considerations.

Plunger Movement Challenges:

• Internal pressure variations may influence plunger position.
• Temperature changes can contribute to slight movement within the syringe barrel.
• Silicone lubrication levels may affect plunger behaviour.
• Transportation vibration can alter stopper positioning.
• Fill volume differences may impact internal package conditions.
• Plunger displacement can influence inspection repeatability if testing parameters are not optimized.

Needle Shield Challenges:

• Dimensional variation may affect sealing consistency.
• Material differences can influence closure performance.
• Assembly tolerances may create variability between packages.
• Small defects near shield interfaces may be difficult to identify visually.
• Environmental exposure may affect elastomeric shield characteristics over time.
• Complex geometries can require highly sensitive inspection methods for accurate evaluation.

Understanding these factors allows manufacturers to better characterize package performance during development and validation activities.

Applications of HVLD and Helium Leak Detection

Advanced deterministic CCIT technologies are frequently selected for pre-filled syringe inspection due to their sensitivity and quantitative measurement capabilities.

High Voltage Leak Detection (HVLD)

High Voltage Leak Detection (HVLD) is a deterministic, non-destructive Container Closure Integrity Testing (CCIT) method used primarily for liquid-filled pharmaceutical packages. The technology applies a high-voltage, MicroCurrent signal across the container and monitors changes in conductivity that may indicate defects such as cracks, pinholes, or seal imperfections. HVLD is particularly suitable for containers filled with conductive or semi-conductive liquids, including injectable drug products. The method provides rapid, repeatable inspection and can be integrated into automated production lines for high-throughput package integrity evaluation.

HVLD applications for pre-filled syringes include:

• Detection of glass cracks
• Identification of pinholes
• Evaluation of closure integrity
• Inspection of needle shield interfaces
• Analysis of seal defects

Helium Leak Detection

Helium Leak Detection is a deterministic Container Closure Integrity Testing (CCIT) method that uses helium tracer gas and a mass spectrometer to detect and measure package leaks with very high sensitivity. During testing, helium is introduced into or around the package, and any escaping helium is measured to determine the presence and size of leak paths. The method can identify extremely small defects that may not be detected by other techniques, making it well suited for package development, validation studies, and quantitative leak-rate analysis. Helium Leak Detection is commonly used for pharmaceutical packaging systems, biologics, pre-filled syringes, and other applications requiring highly sensitive integrity evaluation.

Common applications include:

• Package development studies
• Validation activities
• Stability investigations
• Comparative package evaluations
• Maximum Allowable Leakage Limit (MALL) studies
• Quantitative leak-rate measurement

Conclusion

Pre-filled syringe packaging incorporates multiple sealing interfaces, elastomeric components, and movable elements that require careful evaluation during package integrity assessments. Potential leak locations such as plunger stoppers, needle shields, tip caps, and barrel interfaces can influence package performance throughout manufacturing, storage, and distribution. Factors including plunger movement, closure variability, environmental exposure, and low-headspace configurations add complexity to package inspection. Advanced container closure integrity testing technologies like High Voltage Leak detection (HVLD) and Helium Leak Detection offer highly sensitive methods for identifying defects, measuring leak paths, and generating quantitative data. Through comprehensive package integrity evaluation, manufacturers can gain greater insight into closure performance, support qualification activities, and assess package integrity across the lifecycle of pre-filled syringe products.

Frequently Asked Questions

1. Why is Container Closure Integrity Testing (CCIT) performed on pre-filled syringes?

CCIT is performed on pre-filled syringes to evaluate package integrity and identify potential leak paths that may allow contamination, moisture ingress, gas exchange, or product leakage. The testing process helps manufacturers assess the performance of syringe packaging throughout development, validation, manufacturing, and storage.

2. What are the most common leak locations in pre-filled syringe packaging?

Potential leak locations include needle shield interfaces, plunger stopper regions, glass-to-elastomer contact areas, tip cap sealing surfaces, and cracks within the syringe barrel. These areas may be affected by assembly variations, environmental exposure, or mechanical stress.

3. Which leak detection technologies are commonly used for pre-filled syringe packaging?

High Voltage Leak Detection (HVLD) and Helium Leak Detection are commonly used for pre-filled syringe testing. HVLD is suitable for liquid-filled syringes containing conductive or semi-conductive products and can detect defects such as cracks, pinholes, and seal imperfections. Helium Leak Detection uses helium tracer gas and mass spectrometry to identify extremely small leak paths and generate quantitative leak-rate measurements for package development, validation, and stability studies.

Automated Container Closure Integrity Testing (CCIT) is a specialized form of testing that focuses on verifying the integrity of the container closure systems of several types of containers used to store and transport products. This can include vials, pre-filled syringes, bottles, pouches, and other types of containers. The container closure system includes the closure device (such as a stopper or cap) and the container or package itself (such as a glass or plastic vial or bottle), and it is essential to ensure that it is properly sealed so that it does not allow any leaks or contaminants to enter the container.

Automated CCI testing of pre-filled syringes involve using specialized testing equipment and techniques to simulate real-world conditions and test the container closure system's integrity. This testing process can be done in the laboratory by an operator or fully automated to increase efficiency and accuracy.

Testing Pre-filled Syringes Using E-Scan RTX

The E-Scan RTX platform is a modular, fully automated container closure integrity solution for pre-filled syringes. The RTX is a practical and dependable CCI solution with a dynamic robotic design that is adjusted to meet your production needs. This robust, flexible platform uses MicroCurrent HVLD technology, a revolutionary form of HVLD that is the optimal CCI solution for fragile, high-risk biologic liquids. It is appropriate for batch release testing at the production line, in the lab, and provides a quick PASS/FAIL result with a test cycle of only seconds.

A robotic arm will track and pick up nested syringe trays from a standard single lane conveyor. The robot removes the syringes from the nested tray and rotates the syringes through two test stations, one to detect needle shield defects and the other to inspect the rest of the syringe body. The test starts automatically and gives a fixed PASS/FAIL signal on completion of the test. An adjustable failure reference can be set to allow PASS/FAIL based on a predetermined LOD (limit of detection) setting in the initial recipe. After testing, syringes are automatically loaded back into the syringe tray, defective syringes are collected in the reject tray.

Benefits of E-Scan RTX

• MicroCurrent HVLD technology is effective across all parenteral products, including biologics and extremely low conductivity liquids including sterile water (WFI).
• Listed in USP Chapter 1207 as a recommended method for parenteral liquid package inspection.
• Robust method and good Signal-Noise-Ratio between good and defective products.
• Low voltage exposure reduces the production of ozone.

Automated pre-filled syringe testing is critical to ensuring the safety and efficacy of pre-filled syringes used in the pharmaceutical industry. By using automated testing techniques, manufacturers can ensure that the container closure system is reliable and free from defects, reducing the risk of contamination or other safety concerns.

Several leak detection methods, that are deterministic and non-destructive, are already available in the market. Pharmaceutical companies are urged to use technologies that significantly enhances quality assurance and leak detection rates. Appropriate leak detection technology is selected based on the specific characteristics of the product and container, such as conductivity, headspace parameters, contents, or API. Historically, dye immersion and microbial immersion have been the two main methods of vial integrity testing. Recently, the USP has issued guidelines that require critical methods to achieve more reproducible and predictable outcomes. USP <1207> encourages a move towards more deterministic methods, recommending the avoidance of dye immersion tests and the use of quantitative, non-destructive technologies instead.

Why High Voltage Leak Detection Method is Preferred for Testing Vials?

High Voltage Leak Detection or HVLD is a deterministic, non-destructive leak detection method to evaluate vials, cartridges, and other liquid-filled parenteral products for Container Closure Integrity. The current generation of PTI’s MicroCurrent HVLD may be utilized with a wide range of liquid-based products, from low conductivity sterile water for injection to highly proteinaceous drug preparations in suspensions. It is one of the most effective online container closure testing methods, requiring just minor infrastructure modifications. When compared to conventional HVLD solutions, MicroCurrent HVLD utilizes approximately 50% less voltage and exposes the product and environment to less than 5% of the voltage. This method is non-invasive and requires no sample preparation. Like vial leak testing, another major application of MicroCurrent HVLD is pre-filled syringe testing.

Working Principle of MicroCurrent HVLD Technology

In this method, the container is scanned using a set of high voltage electrode probes. A high voltage is applied to one side of the container, while a ground probe is attached to the other. If there is no leak in the package, the two container walls (high voltage side and ground side) offer complete electrical resistance, and no substantial current is measured flowing through the vial. If a micro-leak or fracture occurs in one of the container walls, the break-down resistance is achieved, and the current flows through. HVLD is the only leak detection method that does not require mass to travel through a defect location, instead of requiring just electricity to pass through a crack. Because of this feature, HVLD is sensitive to leaks that conventional leak detection technologies are unable to detect.

MicroCurrent HVLD Technology Advantages

• Deterministic and non-destructive test method.
• High level of repeatability and accuracy.
• Ensure more accuracy and dependability in results.
• At high production rates, both offline and 100% online inspections are performed.
• Simplifies the inspection and validation procedure.
• Highly effective in all parenteral preparations, even liquids with extremely low conductivity (WFI).
• Outlined in the USP 1207 Guideline.

Pharmaceutical containers like vials protect the product from contamination (sterile barrier) and prevent changes in product quality caused by external factors. In order to determine the functionality of such systems, container closure integrity testing is performed. CCIT provides sophisticated analytical methods for evaluating pharmaceutical containers.